INGN PEER ANALYSIS

Inogen Inc — metric-by-metric comparison with peers and the industry median

INGNInogen Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

INGNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	INGN	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
P/E	—	20.56●	122.41	596.83	—	—	27.44
P/B	0.99	2.48	13.36	1.08	1.32	-74.16●	2.48
EV/EBITDA	—	9.88●	25.46	10.93	34.77	—	15.23
P/S	0.51●	2.09	7.66	1.18	2.95	243.16	2.66

Financial Health
Metric	INGN	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
Current Ratio	3.10	2.57	2.25	3.58	2.31	6.57●	3.28
Debt/Equity	9.3%	62.9%	35.0%	1.0%	28.1%	-22.6%●	44.7%
NetDebt/EBITDA	18.07	1.72	0.42	-1.64●	4.71	0.71	0.82

Profitability
Metric	INGN	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
Net Margin	-7.1%	10.1%●	6.3%	0.2%	-45.0%	-3,684.6%	-5.7%
ROE	-13.1%	12.1%	12.9%●	0.2%	-21.0%	—	-8.6%
ROA	-8.4%	6.1%	8.0%●	0.2%	-15.7%	-264.3%	-6.4%
EBITDA Margin	-1.5%	25.6%	30.6%●	9.4%	9.8%	-818.8%	5.2%

Growth + Dividend
Metric	INGN	SN	ONCSM	MEDTR	ANGEN	4DX	Ind. Median
Rev. Growth	3.4%	—	39.1%●	6.5%	11.7%	-26.0%	7.4%
NI Growth	—	—	—	-62.9%	—	—	16.7%
Div. Yield	—	3.5%●	0.0%	1.1%	0.0%	—	1.1%
Payout	—	52.8%	0.0%	656.3%	0.0%	—	39.0%

Valuation
Metric	INGN	QSI	QTRX	INFU	CVRX	RXST	Ind. Median
P/E	—	—	—	26.83	—	—	27.44
P/B	0.99	1.00	0.72●	3.61	5.07	0.87	2.48
EV/EBITDA	—	—	—	9.01	—	—	15.23
P/S	0.51●	108.75	1.40	1.49	2.50	1.82	2.66

Financial Health
Metric	INGN	QSI	QTRX	INFU	CVRX	RXST	Ind. Median
Current Ratio	3.10	12.60●	3.72	2.14	10.20	10.20	3.28
Debt/Equity	9.3%	1.8%●	12.5%	38.8%	204.0%	4.1%	44.7%
NetDebt/EBITDA	18.07	1.35	0.76	0.80	0.28●	4.79	0.82

Profitability
Metric	INGN	QSI	QTRX	INFU	CVRX	RXST	Ind. Median
Net Margin	-7.1%	-5,605.9%	-71.9%	5.6%●	-89.1%	-36.6%	-5.7%
ROE	-13.1%	-46.4%	-34.8%	13.9%●	-107.0%	-17.1%	-8.6%
ROA	-8.4%	-42.9%	-27.3%	7.8%●	-45.9%	-15.1%	-6.4%
EBITDA Margin	-1.5%	-4,942.7%	-58.4%	18.2%●	-77.8%	-33.9%	5.2%

Growth + Dividend
Metric	INGN	QSI	QTRX	INFU	CVRX	RXST	Ind. Median
Rev. Growth	3.4%	-46.2%	8.2%	3.5%	11.7%●	-19.5%	7.4%
NI Growth	—	—	—	148.0%	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on INGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.